Nianxiang Zou

Title: Nianxiang Zou: Innovator in Gene Delivery Technologies

Introduction

Nianxiang Zou is a prominent inventor based in Homewood, Alabama, known for his contributions to the field of gene delivery technologies. His innovative work focuses on the development of vectors for the transduction of host cells, particularly in relation to human papillomavirus (HPV).

Latest Patents

Zou holds a patent titled "Human papillomavirus vectors for the episomal transduction of host cells and method of making same." This patent describes a replicon designed for the delivery of a transgene, facilitating episomal gene expression in mammalian host cells. The replicon includes a transgene with an open reading frame or other nucleic acid sequence for transcription into RNA, controlled by a first surrogate promoter. Additionally, it features a gene sequence that expresses the papillomavirus replication initiator protein E1 under the control of a second surrogate promoter. The replicon also incorporates a second gene sequence expressing the papillomavirus replication origin binding protein E2, controlled by a third surrogate promoter. Notably, the transgene and the associated sequences are integrated within at least one plasmid and fewer than three plasmids. Zou's innovative approach has the potential to advance gene therapy techniques significantly.

Career Highlights

Nianxiang Zou is affiliated with the UAB Research Foundation at the University of Alabama at Birmingham. His work at this esteemed institution has allowed him to explore and develop groundbreaking technologies in the field of molecular biology and gene therapy.

Collaborations

Zou has collaborated with notable colleagues, including Thomas R. Broker and Louise T. Chow. These partnerships have contributed to the advancement of research in gene delivery systems and their applications in medicine.

Conclusion

Nianxiang Zou's contributions to the field of gene delivery technologies, particularly through his patent on HPV vectors, highlight his role as an innovator in molecular biology. His work continues to pave the way for advancements in gene therapy and related fields.